Current projects

5. Current ADDF Drug Discovery grants

In 2014, Alzheimer's Society joined with the US-based Alzheimer's Drug Discovery Foundation (ADDF) to accelerate the search for new treatments for dementia. This international collaboration offers up to $1.5 million for research projects that focus on repurposing or repositioning exsiting drugs to see if they can benefit people affected by dementia. 

You can read more about the projects that we are currently funding in partnership with the ADDF below.

 

Investigating a rheumatoid arthritis drug as a potential treatment for Alzheimer's disease

Lead Investigator: Professor Clive Holmes

Institution: University of Southampton

Grant awarded: 2015/2016

Themes: Alzheimer's disease; immune system; drug discovery; drug repurposing

 

Testing three drugs to see if they have potential as dementia treatments

Lead Investigator: Professor Giovanna Mallucci

Institution: University of Cambridge

Grant awarded: 2014/2015

Themes: Alzheimer's disease; cause; drug discovery 

 

Investigating the potential of a common drug to treat a cause of vascular dementia and contributor to Alzheimer's disease

Lead Investigator: Dr Atticus Hainsworth

Institution: St George's, University of London 

Grant awarded: 2014/2015

Themes: Vascular dementia; prevention; drug discovery 

 

Testing type-2 diabetes drugs as potential treatments for Alzheimer's disease

Lead Investigator: Professor Christian Holscher

Institution: Lancaster University

Grant awarded: 2014/2015

Themes: Alzheimer's disease; diabetes; drug discovery